SGLT2i are a class of drugs that we hypothesize may have a beneficial effect on these pathways 4 that are not well targeted by current treatment paradigms
After a small draw, the sample is processed to isolate platelets and growth factors, which are then injected into targeted areas
Identified hits from the shape similarity screening were ranked according to their ROCS combo score (Supplementary Table S5)
Rasmussen J, Nielsen OW, Janzen N, Duno M, Gislason H, Kber L, Steuerwald U, Lund AM
Clinical Evidence: Weight Loss Results from Semaglutide Trials The STEP clinical trial program demonstrated semaglutide's weight loss efficacy across multiple patient populations
For most patients, noespecially with slow dose escalation